BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29549644)

  • 1. Safety and General Considerations for the Use of Antibodies in Infectious Diseases.
    Hey AS
    Adv Exp Med Biol; 2017; 1053():265-294. PubMed ID: 29549644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Human Antibody Libraries for Infectious Diseases.
    Chan SK; Lim TS
    Adv Exp Med Biol; 2017; 1053():61-78. PubMed ID: 29549635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic Antibodies in Infectious Disease.
    Chen G; Sidhu SS; Nilvebrant J
    Adv Exp Med Biol; 2017; 1053():79-98. PubMed ID: 29549636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naïve Human Antibody Libraries for Infectious Diseases.
    Chan SK; Rahumatullah A; Lai JY; Lim TS
    Adv Exp Med Biol; 2017; 1053():35-59. PubMed ID: 29549634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Antibodies for the Treatment of Infectious Diseases.
    Fan G; Li J
    Adv Exp Med Biol; 2017; 1053():207-220. PubMed ID: 29549641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies for treating infectious diseases].
    Klinguer-Hamour C; Caussanel V; Beck A
    Med Sci (Paris); 2009 Dec; 25(12):1116-20. PubMed ID: 20035689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.
    Brennan FR; Cauvin A; Tibbitts J; Wolfreys A
    Drug Dev Res; 2014 May; 75(3):115-61. PubMed ID: 24782266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antibodies in the treatment of infectious diseases.
    Chan CE; Chan AH; Hanson BJ; Ooi EE
    Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology.
    Berry JD; Gaudet RG
    N Biotechnol; 2011 Sep; 28(5):489-501. PubMed ID: 21473942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.
    Ter Meulen J
    Infect Dis Clin North Am; 2011 Dec; 25(4):789-802. PubMed ID: 22054756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-based therapies for emerging infectious diseases.
    Casadevall A
    Emerg Infect Dis; 1996; 2(3):200-8. PubMed ID: 8903230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies as anti-infective products: a promising future?
    Pelfrene E; Mura M; Cavaleiro Sanches A; Cavaleri M
    Clin Microbiol Infect; 2019 Jan; 25(1):60-64. PubMed ID: 29715552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies as crypts of antiinfective and antitumor peptides.
    Magliani W; Conti S; Cunha RL; Travassos LR; Polonelli L
    Curr Med Chem; 2009; 16(18):2305-23. PubMed ID: 19519392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies.
    Lynch CM; Hart BW; Grewal IS
    MAbs; 2009; 1(1):2-11. PubMed ID: 20046568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases.
    Dadachova E; Casadevall A
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1075-84. PubMed ID: 16296810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies in infectious diseases: new partners in the therapeutic arsenal].
    Desoubeaux G; Pelegrin M
    Med Sci (Paris); 2019 Dec; 35(12):1008-1013. PubMed ID: 31903909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
    Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
    Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Engineering Antibodies as Drugs: Principles and Practice].
    Lugovskoy AA
    Mol Biol (Mosk); 2017; 51(6):886-898. PubMed ID: 29271954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
    Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
    Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montpellier Infectious Diseases (MID), 2nd annual meeting (2012).
    Bastien P; Braun-Breton C; Chazal N; Devaux C; Foulongne V; Frank M; Hernandez JF; Kremer L; Lebrun M; Le Moing V; Leonetti JP; Lionne C; Peyrottes S
    Infect Genet Evol; 2013 Jun; 16():450-4. PubMed ID: 23416259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.